Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system
Open Access
- 4 May 2005
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 95 (s4), 19-28
- https://doi.org/10.1111/j.1464-410x.2005.05487.x
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Orthostatic hypotensionClinics in Geriatric Medicine, 2002
- A 6‐month large‐scale study into the safety of tamsulosinBritish Journal of Clinical Pharmacology, 2001
- Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort studyClinical Therapeutics, 2001
- Differential vascular α1‐adrenoceptor antagonism by tamsulosin and terazosinBritish Journal of Clinical Pharmacology, 1999
- TamsulosinDrugs, 1996
- Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned α1‐adrenoceptor subtypes and in human prostateJournal of Autonomic Pharmacology, 1996
- The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockersAmerican Heart Journal, 1991
- A double-blind comparative study of doxazosin and prazosin when administered with β-blockers or diureticsAmerican Heart Journal, 1991
- A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapyAmerican Heart Journal, 1988
- The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipineAmerican Heart Journal, 1988